Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Implanon versus DMPA for long-acting reversible contraception
PACTR201701001898417Completed
- Sponsor
- Faculty of Medicine
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of etonogestrel and medroxyprogesterone acetate in contraception, sponsored by Faculty of Medicine. Primary endpoints: Menstrual changes after 3 and 6 months and Changes in uterine artery Doppler indices after 3 and 6 months. Started Dec 2016; status: completed.
02
Drugs
etonogestrelmedroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on PACTR201701001898417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201701001898417.